Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.82)
# 3,283
Out of 5,008 analysts
173
Total ratings
45.21%
Success rate
-1.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $3.36 | +19.05% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $98.43 | +8.71% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $175.75 | -16.36% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $98.83 | -3.88% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $449.69 | +44.54% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.19 | -15.43% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $113.93 | -16.62% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $76.82 | +10.65% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $40.75 | -63.19% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $311.69 | +10.05% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.74 | +704.60% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $23.15 | +107.34% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $76.56 | +33.23% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $96.70 | -40.02% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $14.89 | +34.32% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $66.36 | +97.41% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $133.74 | -0.55% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $366.28 | -39.94% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $127.71 | +195.98% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $3.36
Upside: +19.05%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $98.43
Upside: +8.71%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $175.75
Upside: -16.36%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $98.83
Upside: -3.88%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $449.69
Upside: +44.54%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.19
Upside: -15.43%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $113.93
Upside: -16.62%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $76.82
Upside: +10.65%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $40.75
Upside: -63.19%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $311.69
Upside: +10.05%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.74
Upside: +704.60%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $23.15
Upside: +107.34%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $76.56
Upside: +33.23%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $96.70
Upside: -40.02%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $14.89
Upside: +34.32%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $66.36
Upside: +97.41%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $133.74
Upside: -0.55%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $366.28
Upside: -39.94%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $127.71
Upside: +195.98%